RUBIUS THERAPEUTICS INC

CUSIP: 78116T103 Class: COM

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 17,511 Value ($000) $3 Avg Close Range
Q3 2022
Shares 44,521 Value ($000) $0 Avg Close Range
Q2 2022
Shares 278,908 Value ($000) $0 Avg Close Range
Q1 2022
Shares 384,753 Value ($000) $2,120 Avg Close Range
Q4 2021
Shares 402,841 Value ($000) $3,900 Avg Close Range
Q3 2021
Shares 372,619 Value ($000) $6,662 Avg Close Range
Q2 2021
Shares 165,960 Value ($000) $4,051 Avg Close Range
Q1 2021
Shares 96,151 Value ($000) $2,548 Avg Close Range
Q4 2020
Shares 105,505 Value ($000) $801 Avg Close Range
Q3 2020
Shares 144,595 Value ($000) $724 Avg Close Range
Q2 2020
Shares 119,997 Value ($000) $718 Avg Close Range
Q1 2020
Shares 98,777 Value ($000) $440 Avg Close Range
Q4 2019
Shares 91,610 Value ($000) $871 Avg Close Range
Q3 2019
Shares 67,021 Value ($000) $526 Avg Close Range
Q2 2019
Shares 62,535 Value ($000) $984 Avg Close Range
Q1 2019
Shares 51,205 Value ($000) $927 Avg Close Range
Q4 2018
Shares 35,810 Value ($000) $576 Avg Close Range